NPR News: Drug Puts A $750,000 'Price Tag On Life'

Drug Puts A $750,000 'Price Tag On Life'
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.

Read more on NPR
Health Care
August 2, 2017 at 12:05AM

Blog Beauty 24/7